ANTONIO RAFAEL
CÁLIZ CÁLIZ
PROFESOR CONTRATADO DOCTOR
Sociedad Española de Reumatología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Sociedad Española de Reumatología (9)
2024
-
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis
Reumatologia Clinica, Vol. 20, Núm. 8, pp. 423-439
2023
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Reumatologia Clinica, Vol. 19, Núm. 10, pp. 533-548
2022
-
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry (Rheumatology and Therapy, (2022), 9, 4, (1031-1047), 10.1007/s40744-022-00446-9)
Rheumatology and Therapy
-
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
Rheumatology and Therapy, Vol. 9, Núm. 4, pp. 1031-1047
2019
-
A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics
Reumatologia Clinica, Vol. 15, Núm. 3, pp. 156-164
2017
2015
-
Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide
Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294
2006
-
Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period
Arthritis Research and Therapy, Vol. 8, Núm. 1